An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.
This study has been completed.
Information provided by (Responsible Party):
First received: April 7, 2011
Last updated: July 24, 2017
Last verified: July 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||May 23, 2011|
|Primary Completion Date:||May 23, 2011 (Final data collection date for primary outcome measure)|